No Data
SA Asks: What's the Outlook for Big Pharma M&A?
Earnings Scorecard: 95% of Healthcare Firms Deliver EPS Wins This Week
Here's How Much You Would Have Made Owning Revolution Medicines Stock In The Last 5 Years
Intellia Upgraded at Evercore ISI on Nex-z Hypothesis
Haseko, ZOZO, and Others (Added) Rating
Upgrades - Bullish Code Stock Name Brokerage Previous Revised------------------------------------------------------------<4188> Mitsubishi Chemical GSBI "Neutral" "Buy" <4483> JMDC Tokai Tokyo "Neutral" "Outperform" Downgrades - Bearish Code Stock Name Brokerage Previous Revised-----------------------------------------------
Evercore ISI Group Maintains Outperform on Revolution Medicines, Raises Price Target to $230